Abiomed Announces Expanded Heart Recovery Strategy with Multi Year Growth Initiatives

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Abiomed, Inc. (NASDAQ: ABMD) today presented its expanded heart recovery strategy along with new initiatives that are expected to enhance strong, multi-year double digit sales and earnings growth. During its annual investor and analyst day in New York City, Abiomed will discuss the recently announced PROTECT II clinical and economic developments, the new Symphony™ product, the Company's strategy for long term growth and its new technology pipeline. Specifically, the Company announced a new higher flow Impella device, named Impella cVAD™. Commercial U.S. availability is planned for the summer of 2012. The Company also provided updates on its strategy for market entry into Japan, and announced an estimated Impella market entry timing of 2013. Currently, approximately 25,000 patients are treated in Japan with the intra-aortic balloon pump.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!